Miller John M, Kowal Robert C, Swarup Vijay, Daubert James P, Daoud Emile G, Day John D, Ellenbogen Kenneth A, Hummel John D, Baykaner Tina, Krummen David E, Narayan Sanjiv M, Reddy Vivek Y, Shivkumar Kalyanam, Steinberg Jonathan S, Wheelan Kevin R
Indiana University School of Medicine, Indianapolis, Indiana, USA.
Heartplace, Baylor University Medical Center, Dallas, Texas, USA.
J Cardiovasc Electrophysiol. 2014 Sep;25(9):921-929. doi: 10.1111/jce.12474. Epub 2014 Jul 23.
The success of pulmonary vein isolation (PVI) for atrial fibrillation (AF) may be improved if stable AF sources identified by Focal Impulse and Rotor Mapping (FIRM) are also eliminated. The long-term results of this approach are unclear outside the centers where FIRM was developed; thus, we assessed outcomes of FIRM-guided AF ablation in the first cases at 10 experienced centers.
We prospectively enrolled n = 78 consecutive patients (61 ± 10 years) undergoing FIRM guided ablation for persistent (n = 48), longstanding persistent (n = 7), or paroxysmal (n = 23) AF. AF recordings from both atria with a 64-pole basket catheter were analyzed using a novel mapping system (Rhythm View(TM) ; Topera Inc., CA, USA). Identified rotors/focal sources were ablated, followed by PVI.
Each institution recruited a median of 6 patients, each of whom showed 2.3 ± 0.9 AF rotors/focal sources in diverse locations. 25.3% of all sources were right atrial (RA), and 50.0% of patients had ≥1 RA source. Ablation of all sources required a total of 16.6 ± 11.7 minutes, followed by PVI. On >1 year follow-up with a 3-month blanking period, 1 patient lost to follow-up (median time to 1st recurrence: 245 days, IQR 145-354), single-procedure freedom from AF was 87.5% (patients without prior ablation; 35/40) and 80.5% (all patients; 62/77) and similar for persistent and paroxysmal AF (P = 0.89).
Elimination of patient-specific AF rotors/focal sources produced freedom-from-AF of ≈80% at 1 year at centers new to FIRM. FIRM-guided ablation has a rapid learning curve, yielding similar results to original FIRM reports in each center's first cases.
如果能消除通过局灶冲动与转子标测(FIRM)识别出的稳定房颤源,那么肺静脉隔离(PVI)治疗心房颤动(AF)的成功率可能会提高。在FIRM技术研发中心以外的地方,这种方法的长期效果尚不清楚;因此,我们评估了10个经验丰富的中心在首批病例中采用FIRM指导下房颤消融的结果。
我们前瞻性纳入了连续78例患者(61±10岁),这些患者因持续性房颤(n = 48)、长期持续性房颤(n = 7)或阵发性房颤(n = 23)接受FIRM指导下的消融治疗。使用新型标测系统(Rhythm View™;美国加利福尼亚州Topera公司)分析通过64极篮状导管记录的双心房房颤情况。对识别出的转子/局灶源进行消融,随后进行肺静脉隔离。
每个机构平均招募6例患者,每位患者在不同位置显示出2.3±0.9个房颤转子/局灶源。所有房颤源中25.3%位于右心房(RA),50.0%的患者有≥1个右心房房颤源。消融所有房颤源共需16.6±11.7分钟,随后进行肺静脉隔离。在为期3个月的空白期后进行>1年的随访,1例患者失访(首次复发的中位时间:245天,四分位间距145 - 354天),单次手术无房颤率为87.5%(未接受过消融治疗的患者;35/40)和80.5%(所有患者;62/77),持续性房颤和阵发性房颤的情况相似(P = 0.89)。
对于初次使用FIRM技术的中心,消除患者特异性房颤转子/局灶源在1年时可使无房颤率达到约80%。FIRM指导下的消融学习曲线较快,在每个中心的首批病例中取得了与FIRM原始报告相似的结果。